Ricardo Marek is President of the Growth & Emerging Markets Business Unit (GEM BU), of Takeda Pharmaceutical Company Ltd. He joined Takeda Brazil in 2011, and subsequently became President of the Company’s operations in that country in 2013, progressing to Area Head for Latin America in 2014.
Since 2017, as President of GEM BU, Mr. Marek has been instrumental in re-shaping the Region’s business and in ensuring even greater alignment with Takeda’s highly innovative portfolio across the Company’s five key business areas in almost 50 countries.
Prior to joining Takeda, Mr. Marek was CFO for Organon International in the U.S. and Managing Director and Vice President of Finance for the Akzo Nobel Group, Brazil. He also has experience in other industries, such as chemicals and aerospace.
Mr. Marek holds an MBA from the University of Sao Paulo, Brazil, an extension in his BA in International marketing from UCLA and in Finance from the University of Michigan, USA. He has also successfully completed a CFO Program at Wharton University, USA, and a leadership program at INSEAD, Fontainebleau, France.